Gossamer Bio Stock (NASDAQ: GOSS) stock price, news, charts, stock research, profile.
Open | $1.200 |
Close | $1.180 |
Volume / Avg. | 1.068M / 1.096M |
Day Range | 1.150 - 1.215 |
52 Wk Range | 0.453 - 1.880 |
Market Cap | $266.187M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 5.77% |
Days to Cover | 7.31 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Gossamer Bio (NASDAQ: GOSS) through any online brokerage.
Other companies in Gossamer Bio’s space includes: bluebird bio (NASDAQ:BLUE), FibroGen (NASDAQ:FGEN), Gritstone Bio (NASDAQ:GRTS), Century Therapeutics (NASDAQ:IPSC) and Black Diamond Therapeutic (NASDAQ:BDTX).
The latest price target for Gossamer Bio (NASDAQ: GOSS) was reported by Piper Sandler on Wednesday, March 27, 2024. The analyst firm set a price target for 15.00 expecting GOSS to rise to within 12 months (a possible 1171.19% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Gossamer Bio (NASDAQ: GOSS) is $1.18 last updated March 28, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Gossamer Bio.
Gossamer Bio’s Q4 earnings are confirmed for Thursday, March 2, 2023.
There is no upcoming split for Gossamer Bio.
Gossamer Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.